Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis.

Eur J Case Rep Intern Med

Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Published: April 2021

Unlabelled: We report the case of a 76-year-old man presenting with reactive haemophagocytic lymphohistiocytosis (rHLH) in the setting of disseminated prostate cancer. This often fatal syndrome must be diagnosed early in order to maximize survival. Treatment should be initiated whenever the clinical diagnosis is suspected, even if the HLH-2004 criteria are not met. The HScore is a useful diagnostic tool for rHLH. In case of neurological symptoms, an extensive assessment must be performed. The goal of this case report is to raise awareness of this rare syndrome among oncologists.

Learning Points: The association of prostate cancer and reactive haemophagocytic lymphohistiocytosis (rHLH) has rarely been described.This often fatal syndrome must be recognized early in order to start specific treatment and maximize survival.Specific treatment for rHLH must be accompanied by treatment of the triggering factors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112095PMC
http://dx.doi.org/10.12890/2021_002425DOI Listing

Publication Analysis

Top Keywords

prostate cancer
12
reactive haemophagocytic
12
haemophagocytic lymphohistiocytosis
12
cancer reactive
8
lymphohistiocytosis rhlh
8
fatal syndrome
8
early order
8
lymphohistiocytosis unlabelled
4
unlabelled report
4
report case
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!